- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Phagocyte.
Displaying page 1 of 1.
EudraCT Number: 2015-001472-22 | Sponsor Protocol Number: IMUNOR-201501 | Start Date*: 2017-03-14 | |||||||||||
Sponsor Name:ImunomedicA, a.s. | |||||||||||||
Full Title: A Prospective, Randomized, Double-Blind, Placebo-controlled, Multicenter, Phase III Study Assessing Efficacy and Safety of the IMUNORĀ® Therapy Versus Placebo in Patients with Recurrent Vulvovaginit... | |||||||||||||
Medical condition: Recurrent vulvovaginitis episodes | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SK (Completed) CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002479-28 | Sponsor Protocol Number: MOL-ARDS-002 | Start Date*: 2015-09-24 | |||||||||||
Sponsor Name:Justus-Liebig University | |||||||||||||
Full Title: GM-CSF Inhalation to improve HOst defense and Pulmonary barrier rEstoration | |||||||||||||
Medical condition: Pneumonia associated Acute Respiratory Distress Syndrome (ARDS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003956-18 | Sponsor Protocol Number: PREVENT-JIA | Start Date*: 2014-04-29 | |||||||||||
Sponsor Name:University Medical Center Utrecht | |||||||||||||
Full Title: Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis (JIA) | |||||||||||||
Medical condition: juvenile idiopathic arthritis | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001697-17 | Sponsor Protocol Number: R1979-ONC-1504 | Start Date*: 2015-12-01 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Regeneron Pharmaceuticals, Inc | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A Phase 1 Study to Assess Safety and Tolerability of REGN1979, an anti-CD20 x anti- CD3 bispecific monoclonal antibody, and REGN2810, an anti-programmed death-1 monoclonal antibody, in Patients wit... | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: B-cell malignancies | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Completed) ES (Temporarily Halted) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.